Role of MicroRNAs in Lung Disease

被引：95

作者：

Angulo, Martin ^{[1
,2
]}

Lecuona, Emilia ^{[1
]}

Iasha Sznajder, Jacob ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care, Chicago, IL 60611 USA

[2] Univ Republica, Fac Med, Hosp Clin, Dept Fisiopatol, Montevideo, Uruguay

来源：

ARCHIVOS DE BRONCONEUMOLOGIA | 2012年 / 48卷 / 09期

关键词：

MicroRNA; Lung disease; Smoking; Chronic obstructive pulmonary disease; Lung cancer; Pulmonary fibrosis; Lung injury; Asthma; OBSTRUCTIVE PULMONARY-DISEASE; DOWN-REGULATION; REDUCED EXPRESSION; CANCER; SURVIVAL; TARGET; MUSCLE; SPUTUM; CELLS; IDENTIFICATION;

D O I：

10.1016/j.arbres.2012.04.011

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

MicroRNAs (miRNAs) are small non-coding RNA molecules that negatively regulate gene expression. They actively participate in the modulation of important cell physiological processes and are involved in the pathogenesis of lung diseases such as lung cancer, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease. A better understanding of the role that miRNAs play in these diseases could lead to the development of new diagnostic and therapeutic tools. In this review, we discuss the role of some miRNAs in different lung diseases as well as the possible future of these discoveries in clinical applications. (C) 2012 SEPAR. Published by Elsevier Espana, S.L. All rights reserved.

引用

页码：325 / 330

页数：6

共 76 条

[21] Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
[22] In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
Karreth, Florian A.
Tay, Yvonne
Perna, Daniele
Ala, Ugo
Tan, Shen Mynn
Rust, Alistair G.
DeNicola, Gina
Webster, Kaitlyn A.
Weiss, Dror
Perez-Mancera, Pedro A.
Krauthammer, Michael
Halaban, Ruth
Provero, Paolo
Adams, David J.
Tuveson, David A.
Pandolfi, Pier Paolo
[J]. CELL, 2011, 147 (02) : 382 - 395
[23] Reduced expression of Dicer associated with poor prognosis in lung cancer patients
Karube, Y
Tanaka, H
Osada, H
Tomida, S
Tatematsu, Y
Yanagisawa, K
Yatabe, Y
Takamizawa, J
Miyoshi, S
Mitsudomi, T
Takahashi, T
[J]. CANCER SCIENCE, 2005, 96 (02): : 111 - 115
[24] Idiopathic pulmonary fibrosis
King, Talmadge E., Jr.
Pardo, Annie
Selman, Moises
[J]. LANCET, 2011, 378 (9807) : 1949 - 1961
[25] Chronic Obstructive Pulmonary Disease and Altered Risk of Lung Cancer in a Population-Based Case-Control Study
Koshiol, Jill
Rotunno, Melissa
Consonni, Dario
Pesatori, Angela Cecilia
De Matteis, Sara
Goldstein, Alisa M.
Chaturvedi, Anil K.
Wacholder, Sholom
Landi, Maria Teresa
Lubin, Jay H.
Caporaso, Neil E.
[J]. PLOS ONE, 2009, 4 (10):
[26] miRBase: integrating microRNA annotation and deep-sequencing data
Kozomara, Ana
Griffiths-Jones, Sam
[J]. NUCLEIC ACIDS RESEARCH, 2011, 39 : D152 - D157
[27] The widespread regulation of microRNA biogenesis, function and decay
Krol, Jacek
Loedige, Inga
Filipowicz, Witold
[J]. NATURE REVIEWS GENETICS, 2010, 11 (09) : 597 - 610
[28] THE C-ELEGANS HETEROCHRONIC GENE LIN-4 ENCODES SMALL RNAS WITH ANTISENSE COMPLEMENTARITY TO LIN-14
LEE, RC
FEINBAUM, RL
AMBROS, V
[J]. CELL, 1993, 75 (05) : 843 - 854
[29] Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
Lewis, Amy
Riddoch-Contreras, Joanna
Natanek, Samantha A.
Donaldson, Anna
Man, William D-C
Moxham, John
Hopkinson, Nicholas S.
Polkey, Michael I.
Kemp, Paul R.
[J]. THORAX, 2012, 67 (01) : 26 - 34
[30] MicroRNA in lung cancer
Lin, P-Y
Yu, S-L
Yang, P-C
[J]. BRITISH JOURNAL OF CANCER, 2010, 103 (08) : 1144 - 1148

← 1 2 3 4 5 6 7 8 →